Pacific Edge | PEB - Cost Of Sales

Stock Price
0.20
Daily Change
0.003 1.56%
Monthly
0.52%
Yearly
48.86%
Q2 Forecast
0.17

Pacific Edge reported NZD280K in Cost of Sales for its fiscal semester ending in March of 2024.





Cost Of Sales Change Date
Avita Medical AUD 3.3M 166K Dec/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025